USPTO serial 98050125
OPIS
Reviewed by CopyMark Law Group
Status 654
- Filing date
- Status date
- Registration date
- —
- Examiner
- DIGAN, MATTHEW M
- Law office
- TMO LAW OFFICE 124
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with OPIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
James L. Scott
James L. Scott PRIVUS PLC7125 HEADLEY STREET SEUNIT 1084ADA, MI 49301Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Help in the management of business affairs or commercial functions of an industrial or commercial enterprise; analysis of market studies; analysis of market research statistics; market research and analysis; statistical analysis and reporting services for business purposes; business advice and consultancy; compilation of statistics; computerized data processing; electronic data processing; providing of commercial statistical information in the medical field; business management of hospitals; maintaining personal medical history records and files; maintaining files and records concerning the medical condition of individuals; marketing studies; preparation of market reports and studies; collating of data in computer databases in the nature of analyzing and compiling business data; conducting business and market research surveys; administrative management of health care clinics; compilation of statistics relating to health care utilization for business or commercial purposes; data processing services in the field of healthcare; data processing services in the nature of automated processing of medical data; management and compilation of computerized databases; compilation of information into computer databases; advertising services to promote public awareness of medical issues | ACTIVE | — |
| 042 | Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; biological and medical research; biochemistry research services; biotechnology research; pharmaceutical research; laboratory research in the field of pharmaceuticals; biological research; medical research; scientific research; bacteriological research and analysis; bacteriological research and testing; research and development services relating to vaccines and medicines; pharmaceutical research and development; scientific and medical research and development; medical and scientific research in the field of pharmacogenetics; biological research and analysis; chemical research and analysis; scientific research and analysis; chemical research; medical research laboratory services; laboratory research and analysis in the fields of pharmaceuticals and biotechnology; consultancy and laboratory research in the field of bacteriology; research and development services in the field of biochemistry; research and development services in the field of pharmaceutical preparations; research in the field of artificial intelligence technology; scientific research in the field of genetics and genetic engineering; research and development of vaccines; preparation of scientific reports relating to scientific research; pharmaceutical drug development services; drug discovery services; scientific research in the nature of conducting clinical trials for others; medical and scientific research, namely, conducting clinical trials for others; scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical drugs; product design and development in the field of medical technology; providing medical and scientific information about the results of clinical trials in the field of pharmaceuticals; design and development of computer software for database management and data processing in the field of medical technology; testing, analysis and evaluation of the goods of others to determine conformity with certification standards; design and testing of new products for others; pharmaceutical testing | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 6, 2026 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jul 4, 2026 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jan 3, 2026 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jan 2, 2026 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jul 1, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jul 1, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Dec 31, 2024 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jun 28, 2024 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jun 28, 2024 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jun 28, 2024 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jun 4, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 4, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 4, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 4, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 28, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 23, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 23, 2023 | NWAP | NEW APPLICATION ENTERED | — |